炎症
甘露糖受体
免疫学
受体
结肠炎
巨噬细胞
下调和上调
炎症体
白三烯B4
生物
生物化学
基因
体外
作者
Mouna Rahabi,Godefroy Jacquemin,Mélissa Prat,Étienne Meunier,Mohamad Alaeddine,Bénédicte Bertrand,Lise Lefèvre,Khaddouj Benmoussa,Philippe Batigne,Agnès Aubouy,Johan Auwerx,Sylvain Kirzin,Delphine Bonnet,Marie Danjoux,Bernard Pipy,Laurent Alric,Hélène Authier,Agnès Coste
出处
期刊:Cell Reports
[Cell Press]
日期:2020-03-01
卷期号:30 (13): 4386-4398.e5
被引量:54
标识
DOI:10.1016/j.celrep.2020.03.018
摘要
Colonic macrophages are considered to be major effectors of inflammatory bowel diseases (IBDs) and the control of gut inflammation through C-type lectin receptors is an emerging concept. We show that during colitis, the loss of dectin-1 on myeloid cells prevents intestinal inflammation, while the lack of mannose receptor (MR) exacerbates it. A marked increase in dectin-1 expression in dextran sulfate sodium (DSS)-exposed MR-deficient mice supports the critical contribution of dectin-1 to colitis outcome. Dectin-1 is crucial for Ly6ChighCCR2high monocyte population enrichment in the blood and their recruitment to inflamed colon as precursors of inflammatory macrophages. Dectin-1 also promotes inflammasome-dependent interleukin-1β (IL-1β) secretion through leukotriene B4 production. Interestingly, colonic inflammation is associated with a concomitant overexpression of dectin-1/CCL2/LTA4H and downregulation of MR on macrophages from IBD patients. Thus, MR and dectin-1 on macrophages are important mucosal inflammatory regulators that contribute to the intestinal inflammation.
科研通智能强力驱动
Strongly Powered by AbleSci AI